LIN452 NCT02855164


Laboratory : NOVARTIS

Study Name : 

Phase 2

Study Number : NCT02855164

Number of patients recruited : 250

Probability to be under placebo : 16%

Contacts : 

Contact: Novartis Pharmaceuticals

1-888-669-6682

Contact: Novartis Pharmaceuticals

+41 613241111






Share on StockTwits

WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE